Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L. Citron ML, et al. Among authors: leung eh. J Clin Oncol. 2003 Apr 15;21(8):1431-9. doi: 10.1200/JCO.2003.09.081. Epub 2003 Feb 13. J Clin Oncol. 2003. PMID: 12668651 Clinical Trial.
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).
Rugo HS, Barry WT, Moreno-Aspitia A, Lyss AP, Cirrincione C, Leung E, Mayer EL, Naughton M, Toppmeyer D, Carey LA, Perez EA, Hudis C, Winer EP. Rugo HS, et al. J Clin Oncol. 2015 Jul 20;33(21):2361-9. doi: 10.1200/JCO.2014.59.5298. Epub 2015 Jun 8. J Clin Oncol. 2015. PMID: 26056183 Free PMC article. Clinical Trial.
Minimally Invasive Glaucoma Surgery: Latest Developments and Future Challenges.
Chan PPM, Larson MD, Dickerson JE Jr, Mercieca K, Koh VTC, Lim R, Leung EHY, Samuelson TW, Larsen CL, Harvey A, Töteberg-Harms M, Meier-Gibbons F, Shu-Wen Chan N, Sy JB, Mansouri K, Zhang X, Lam DSC. Chan PPM, et al. Among authors: leung ehy. Asia Pac J Ophthalmol (Phila). 2023 Nov-Dec 01;12(6):537-564. doi: 10.1097/APO.0000000000000646. Epub 2023 Nov 27. Asia Pac J Ophthalmol (Phila). 2023. PMID: 38079242 Review.
Opportunity Cost of Vitreoretinal Surgeries.
Leung EH, Patel S, Reddy R, Boucher N, Sharma C, Blim J, Ferrone PJ, Hahn P; American Society of Retina Specialists Health Economics Committee. Leung EH, et al. J Vitreoretin Dis. 2023 Jun 17;7(4):275-280. doi: 10.1177/24741264231178590. eCollection 2023 Jul-Aug. J Vitreoretin Dis. 2023. PMID: 37927325
Opportunity Cost of Retinal Detachment Surgery vs Office-Based Patient Care.
Leung EH, Leder HA, Patel S, Reddy R, Boucher N, Sharma C, Blim J, Awh C, Hahn P; American Society of Retina Specialists Health Economics Committee. Leung EH, et al. J Vitreoretin Dis. 2022 Jul 16;6(4):278-283. doi: 10.1177/24741264221098669. eCollection 2022 Jul-Aug. J Vitreoretin Dis. 2022. PMID: 37007922 Free PMC article.
Reprogramming cell fates towards novel cancer immunotherapies.
Leung EHW, Joves K, Petenkaya A, Barham G, Henderson TG, Liang J, Chronis C. Leung EHW, et al. Curr Opin Pharmacol. 2022 Dec;67:102312. doi: 10.1016/j.coph.2022.102312. Epub 2022 Nov 3. Curr Opin Pharmacol. 2022. PMID: 36335715 Review.
57 results